On November 17th, HOOD fell by 7.35% to $72.06, further approaching the demand zone of $65.
A series of recurring EMA death cross patterns, similar to the bearish trend observed in the first quarter of 2026.
A former Robinhood engineer admitted to trading on Hyperliquid using confidential listing data.
After almost doubling from around $65 at the end of March to $126 on September 12, this round of rebound has now taken a sharp turn for the worse. Technical damage is worsening, and the possibility of further declines cannot be ruled out.
HOOD Stock price loses two important support levels
Robinhood maintained an upward trend line from the low point at the end of March until September. In October, this structure was broken, and the stock price fell below the support of the trend line near the $95 level.

If another test fails, the stock price is likely to experience a more significant decline, and $40 could become a downward target area. This is a risk scenario, not a confirmed target.
EMA Death Cross Reappears with Familiar Bearish Signal
The moving average combination is intensifying concerns. In the first quarter of 2026, there was a death cross between the 20-day EMA and the 200-day EMA indicator, around $95 at that time. Subsequently, the HOOD indicator fell to $65.
Subsequently, the second bearish signal between the 50-day EMA and the 200-day EMA also accompanied this round of continued decline.
Now, similar signals have reappeared in the fourth quarter. On the 20th, the death cross of the 20-day and 200-day EMA indicators occurred again around $95, followed by a cross between the 50-day and 200-day EMA indicators.
This similarity is hard to ignore. However, technical patterns cannot guarantee exactly the same outcome. The $65 range could trigger a strong rebound, or it could fall below that level under new selling pressure.
Robinhood Insider Fraud Case Brings New Pressure
He agreed to forfeit $125,523. The prosecution stated that these actions involved at least 11 listing announcements between 2025 and 2026. The sentencing is scheduled for February 25, 2027.
The case has raised concerns from the outside world regarding internal controls and confidential listing data. However, the information provided does not prove that this confession directly led to the 7.35% decline on November 17th.
Regarding the stock price of HOOD, the most immediate technical challenge at present is clear: if it can hold above $65, a rebound is still possible; however, if it falls below $65, the risk of a decline to $40 becomes more difficult to ignore.









